yc 170 has been researched along with nifedipine in 13 studies
| Studies (yc 170) | Trials (yc 170) | Recent Studies (post-2010) (yc 170) | Studies (nifedipine) | Trials (nifedipine) | Recent Studies (post-2010) (nifedipine) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 16,024 | 2,496 | 1,505 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimoto, T; Ariyoshi, S; Fujisue, T; Ichida, S; Wada, T | 1 |
| Aimi, N; Horie, S; Horiuchi, H; Sakai, S; Watanabe, K; Yano, S | 1 |
| Ogawa, N | 1 |
| Brooks, HL; Gross, GJ; Preuss, KC; Warltier, DC | 1 |
| Criscione, L; Meier, M; Rogg, H; Truog, A | 1 |
| Schramm, M; Towart, R | 1 |
| Hattori, Y; Kanno, M; Nakaya, H; Tohse, N | 2 |
| Handa, J; Kidooka, M; Matsuda, M | 1 |
| Asano, M; Inagaki, O; Kubo, K; Takenaka, T; Terai, M | 1 |
| Takeda, Y | 1 |
| Eto, Y; Tokoro, T; Yamamoto, T | 1 |
| Kanno, M; Nakaya, H; Takeda, Y; Tohse, N | 1 |
2 review(s) available for yc 170 and nifedipine
| Article | Year |
|---|---|
Slow channel calcium activators, a new group of pharmacological agents.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Blood Pressure; Calcium; Calcium Channel Blockers; Cells, Cultured; Heart; Heart Rate; Ion Channels; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Nifedipine; Pyridines; Stimulation, Chemical; Vascular Resistance | 1985 |
Modulation of calcium channel function by drugs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Dihydropyridines; Electric Conductivity; Heart Rate; Homeostasis; Humans; Ion Channels; Membrane Potentials; Nifedipine; Pyridines; Receptors, Cell Surface; Structure-Activity Relationship | 1985 |
11 other study(ies) available for yc 170 and nifedipine
| Article | Year |
|---|---|
Effects of calcium channel agonists (BAY K 8644, CGP28392 and YC-170) on 45Ca uptake by rat uterine segments.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channels; Female; Nifedipine; Nitrendipine; Potassium Chloride; Pyridines; Rats; Rats, Inbred Strains; Uterus | 1991 |
Ca2+ channel blocking effects of hirsutine, an indole alkaloid from Uncaria genus, in the isolated rat aorta.
Topics: Alkaloids; Animals; Aorta; Calcimycin; Calcium Channel Blockers; Drugs, Chinese Herbal; In Vitro Techniques; Male; Nifedipine; Norepinephrine; Potassium; Rats; Rats, Inbred Strains; Serotonin; Vasodilator Agents | 1991 |
Effect of nicardipine on the relationship of renal blood flow and of renal vascular resistance to perfusion pressure in dog kidney.
Topics: Animals; Blood Pressure; Calcium Channel Agonists; Dogs; Dose-Response Relationship, Drug; Female; Male; Nicardipine; Nifedipine; Perfusion; Renal Circulation; Vascular Resistance; Vasoconstriction | 1990 |
In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding, Competitive; Biological Transport; Calcium; Guinea Pigs; Heart Rate; In Vitro Techniques; Ion Channels; Male; Mesentery; Myocardial Contraction; Nifedipine; Nitrendipine; Pyridines; Rats; Vasoconstriction | 1985 |
Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Aorta; Calcium; Female; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Ion Channels; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Potassium; Rabbits; Vasoconstriction | 1986 |
Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Cardiovascular System; Female; Guinea Pigs; Heart; Histamine; In Vitro Techniques; Ion Channels; Isoproterenol; Male; Muscle, Smooth; Nifedipine; Potassium; Rabbits; Sinoatrial Node; Tetraethylammonium Compounds | 1986 |
Effect of calcium antagonist and agonist on free fatty acid liberation in the ischemic brain of rats.
Topics: Animals; Arachidonic Acids; Brain; Brain Ischemia; Disease Models, Animal; Fatty Acids, Nonesterified; Ion Channels; Male; Nicardipine; Nifedipine; Oleic Acids; Palmitic Acids; Rats; Rats, Inbred Strains; Stearic Acids | 1987 |
New 1,4-dihydropyridines with vasoconstrictor action through activation of Ca++-channels.
Topics: Animals; Blood Pressure; Calcium; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; In Vitro Techniques; Ion Channels; Male; Nifedipine; Nitrendipine; Rabbits; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Vasoconstriction; Vasoconstrictor Agents | 1988 |
[Single channel analysis of Ca2+ channel-agonistic action of dihydropyridine derivatives: voltage-dependent effects of YC-170 and BAY K 8644].
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channels; Dihydropyridines; Membrane Potentials; Myocardium; Nifedipine; Rabbits | 1993 |
The attenuated elevation of cytoplasmic calcium concentration following the uptake of low density lipoprotein in type C Niemann-Pick fibroblasts.
Topics: Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cells, Cultured; Cholesterol, LDL; Cytoplasm; Epidermal Cells; Fibroblasts; Humans; Lipoproteins, LDL; Niemann-Pick Diseases; Nifedipine; Oleic Acid; Oleic Acids | 1994 |
Voltage-dependence of Ca2+ agonist effect of YC-170 on cardiac L-type Ca2+ channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channels; Heart; Myocardium; Nifedipine; Patch-Clamp Techniques; Pyridines; Rabbits | 1995 |